Double threat: HIV and hepatitis B co-infection increases risk of kidney dysfunction

A new 10-year regional study reveals that adults living with both HIV and hepatitis B virus across the Asia-Pacific face ...
Nature

HIV-1 Infection and T Cell Responses

The global challenge posed by HIV-1 infection continues to drive research into its underlying mechanisms and the host immune response. Central to this pursuit is the role of T cells, particularly CD4 ...
Monthly Prescribing Reference

Twice-Yearly HIV-1 PrEP Yeztugo Gets FDA Approval

Credit: Gilead. Yeztugo (lenacapavir) is an HIV-1 capsid inhibitor that is administered every 6 months after an initial dosing regimen. Yeztugo demonstrated superiority over Truvada in reducing the ...
Fred Hutch

HIV’s secret sweet tooth: T cell glycosylation determines variant entry

At the cellular level, HIV-1 transmission involves a highly coordinated process whereby the virus binds to CD4 receptors and one of two coreceptors—CCR5 (R5) or CXCR4 (X4)—on host immune cells, ...
Yahoo

HIV infections can be prevented – why some people act to protect themselves, and others don’t

The number of new HIV infections has fallen over the years – it declined by 39% from 2010 to 2023. But HIV’s devastating impact on global health persists. In 2023, 1.3 million people acquired HIV – ...

Sedia Biosciences Receives WHO Pre-Qualification for its Asanté® HIV-1/2 Oral Fluid Test

BEAVERTON, OR, UNITED STATES, January 13, 2026 /EINPresswire.com/ -- Sedia Biosciences Corporation, a leading developer ...
News-Medical.Net

Study reveals genetic signatures linked to HIV-related cognitive impairment

Using participant skin cells reprogrammed into neurons, Weill Cornell Medicine researchers have identified genetic signatures ...